Showing results (61-70 of 88) with videos related to

Sort By:
Pageof 9
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1975
Properties of oncornavirus RNA-directed DNA polymerase, the RNA template, and the intracellular products formed early during infection and cell transformationM Green, D Grandgenett, G Gerard, et al.
Cell Chemical Biology|October 24, 2017
Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7Ilaria Lamberto, Xiaoxi Liu, Hyuk-Soo Seo, et al.
Experimental Hematology & Oncology|July 31, 2026
Arsenic trioxide promotes a glue‑like interaction to drive STUB1-mediated NPM-ALK degradation in ALK+ ALCLGuiming Li, Jun Wang, Shiguang Ye, et al.
European Journal of Medicinal Chemistry|October 30, 2025
Allosteric inhibition of JAK2 with lysine-reactive compounds that bind the pseudokinase domainMarina C Primi, Maurício T Tavares, John M Hatcher, et al.
Leukemia|February 24, 2015
Pathological glycogenesis through glycogen synthase 1 and suppression of excessive AMP kinase activity in myeloid leukemia cellsHaymanti Bhanot, Mamatha M Reddy, Atsushi Nonami, et al.
Oncotarget|September 9, 2017
Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinaseEllen L Weisberg, Alexandre Puissant, Richard Stone, et al.
Bioorganic & Medicinal Chemistry|January 1, 2017
Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitorsLi Tan, Deepak Gurbani, Ellen L Weisberg, et al.
ACS Chemical Biology|August 1, 2013
Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitorHyung-Gu Kim, Li Tan, Ellen L Weisberg, et al.
Cancers|December 30, 2020
Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM)Moshe Lapidot, Abigail E Case, Dalia Larios, et al.
Bioorganic & Medicinal Chemistry|December 25, 2016
Structure-guided development of covalent TAK1 inhibitorsLi Tan, Deepak Gurbani, Ellen L Weisberg, et al.
Pageof 9